Issues

Health Care

PublicationsMore »

FDA Regulation in the Data-Driven Economy

The shift to data-driven growth is one of the most important forces behind the strong performance of the U.S. economy in recent years. Online sales…

Tracking Healthcare Cost Growth Through a New Measure of Productivity

This brief provides a new explanation for why healthcare cost growth is showing restraint. Specifically, we find evidence that the healthcare sector is finally managing…

How Rising Health Costs Slow Wage Growth

Most Americans are painfully aware that their health care premiums are rising faster than other necessities of life. Many also know that their earnings are…

PressMore »

WSJ: The Folly of Targeting Big Pharma

An unfortunate refrain among Democratic presidential hopefuls is that rapacious pharmaceutical and biotech companies are driving up the cost of essential medications, bankrupting the health-care…

The Sacramento Bee: Science, not politics, should drive California regs on BPA

As the presidential campaign season gets underway, it reminds us how much we loath the politics of fear mongering. Half-truths and half-baked policy proposals have…

Carew for Republic 3.0: The Case for a Data-Driven FDA

The Food and Drug Administration (FDA) is fast finding itself at the center of the debate over healthcare regulation in the 21st century. At issue:…

BlogMore »

Why Obamacare is the heart of the new pro-growth, pro-middle class, pro-entrepreneur Democratic Party (sorry, Senator Schumer)

Senator Schumer has made a plausible argument for why Obamacare was a political mistake.  I disagree. Democratic politicians have mainly defended Obamacare on the grounds…

EventsMore »

Upcoming Events
No Upcoming Events
Past Events
No Upcoming Events